Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: insights value based payments cms vision for 2030
… Early Cost-Effectiveness Model for Gene Therapy OPPORTUNITY Our client asked us to develop … around the target population, identify data gaps and the value of filling them, and provide economically justifiable … a gene therapy. OUR APPROACH Our team developed a cohort-based early CEM with a lifetime time horizon reflecting …
… health markets and to develop and gain market access for products to treat psychiatric and mental health illnesses … patients, caregivers and heath care professionals Global Value Dossiers Literature reviews Meta-analysis studies … and implementation Treatment preferences studies Value communication strategies …
… Preference Assessment Do you know what your patients value and what they would be willing to trade-off (or pay for) to get what is important to them? For example, if your … Product development strategies Product positioning and value messages Market segmentation Product uptake estimates …
… Contributed by: Anne Heyes, MBA Vice President, Head of Value & Access, Europe RTI Health Solutions With the EU's … been finalised. Anne Heyes, Vice President and Head of Value and Access at RTI Health Solutions, has more than 30 … EU JCAs. Companies could find choosing to pursue research for the larger rather than the smaller and rarer populations …
… as their current and former caregivers and those at risk for developing any of these conditions. With the …
… autoimmune market and to develop and gain market access for products to treat autoimmune diseases and complications … Epidemiology of disease Measurement of patient preferences for treatment options Outcomes research strategy development …
… quality of life with efficacy outcomes in the VISION study of patients with metastatic castration-resistant …
… in the CNS market and to develop and gain market access for products to treat CNS diseases and complications arising … evaluations of PRO instruments Reimbursement and value communication strategies Retrospective observational …
… Is EQ-5D an Appropriate Health Utility Assessment for Your Patient Population? Share on: November 19, 2024 Fully Portray the Clinical and Economic Value of Your Product Contributed by: Sorrel Wolowacz, PhD … Alternatives to EQ-5D include other generic preference-based measures, condition-specific measures, mapping, direct …
… adverse events. Treatment attributes are relative based on a person’s understanding of their disease state, … inform your drug development and market access strategies. For your project, we conduct the following: Identify … target subjects. We then test the survey and modify it based testing results. Finalize the survey: We finalize the …